Literature DB >> 3198128

Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes.

G Rittner1, G Schwanitz, M P Baur, C M Black, K I Welsh, P Kühnl, C Rittner.   

Abstract

An increased chromosomal breakage rate (ICBR) was found in 27 of 28 patients with scleroderma (systemic sclerosis, SS) - 5 with the syndrome including calcinosis cutis, Raynaud phenomenon, esophagus hypomotility, sclerodactyly and telangiectasia (CREST), 4 incomplete CREST, 1 overlapping syndrome, 18 progressive systemic sclerosis (PSS). Not only the patients, but also about half of their first-degree relatives showed an increased chromosomal breakage rate (more than 5 breaks per 100 metaphases). This character segregated as a dominant marker in nine families of scleroderma patients. In the six informative of the nine families, the ICBR trait showed close linkage with the HLA region on chromosome 6 (total lod score 5.5 at theta = 0). In these families, ICBR was predominantly observed in linkage with HLA haplotype A1, Cw7, B8, C4AQ0B1, DR3 which is frequently observed in autoimmune diseases. The nature of the agent inducing chromosomal breakage in cultured lymphocytes of some, but not all family members of scleroderma patients remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198128     DOI: 10.1007/bf00283732

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Chromosome preparations of leukocytes cultured from human peripheral blood.

Authors:  P S MOORHEAD; P C NOWELL; W J MELLMAN; D M BATTIPS; D A HUNGERFORD
Journal:  Exp Cell Res       Date:  1960-09       Impact factor: 3.905

2.  Sequential tests for the detection of linkage.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1955-09       Impact factor: 11.025

3.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

4.  Chromosome studies in 14 patients with disseminated sclerosis.

Authors:  I Emerit; R Marteau
Journal:  Humangenetik       Date:  1971

5.  Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes.

Authors:  C Rittner; C M Giles; M H Roos; P Démant; E Mollenhauer
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Scleroderma: possible significance of silent alleles at the C4B locus.

Authors:  E Mollenhauer; R Schmidt; M Heinrichs; C Rittner
Journal:  Arthritis Rheum       Date:  1984-06

7.  Chromosomal instability in collagen disease.

Authors:  I Emerit
Journal:  Z Rheumatol       Date:  1980 Mar-Apr       Impact factor: 1.372

8.  Chromosomal instability in NZB/BL mice. A dominant trait.

Authors:  A Levy; I Emerit; J Feingold
Journal:  Biomed Pharmacother       Date:  1982-01       Impact factor: 6.529

9.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants.

Authors:  P M Schneider; M C Carroll; C A Alper; C Rittner; A S Whitehead; E J Yunis; H R Colten
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

10.  Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.

Authors:  M H Roos; C M Giles; P Demant; E Mollenhauer; C Rittner
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

View more
  10 in total

1.  Scleroderma and chronic myeloid leukemia: a sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases?

Authors:  Timuçin Kaşifoğlu; Cengiz Korkmaz; Sule Yaşar; Zafer Gülbaş
Journal:  Rheumatol Int       Date:  2006-07-27       Impact factor: 2.631

2.  Chromosome abnormalities in peripheral lymphocytes from patients with progressive systemic sclerosis.

Authors:  F Takeuchi; K Nakano; H Yamada; E Kosuge; M Hirai; H Maeda; Y Moroi
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

3.  Chromosomal aberrations in patients with primary biliary cirrhosis.

Authors:  A Notghi; U Nestle; G Rittner; P Brissot; H Jouanolle; M Manns; E Schleiermacher; C Rittner
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

4.  Risk of cancer in patients with scleroderma: a population based cohort study.

Authors:  C L Hill; A-M Nguyen; D Roder; P Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

Review 5.  Clinical aspects of systemic sclerosis (scleroderma).

Authors:  R M Silver
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

6.  Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies.

Authors:  K Banki; J Maceda; E Hurley; E Ablonczy; D H Mattson; L Szegedy; C Hung; A Perl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

7.  Association of malignant glioma with the human leukocyte antigen, HLA-A24(9).

Authors:  T Nitta; M Ebato; K Sato
Journal:  Neurosurg Rev       Date:  1994       Impact factor: 3.042

8.  Risk factors for malignancy in systemic sclerosis patients.

Authors:  T Kaşifoğlu; Ş Yaşar Bilge; F Yıldız; G Özen; Y Pehlivan; N Yılmaz; F Tarhan; S Yılmaz; A Küçük; H Emmungil; S S Koca; M Çınar; H Direskeneli; E Erken; G Can; M Özmen; E Gönüllü; B Kisacik; K Aksu; O Karadağ; N Kasifoglu; D Arslantas; F Sahin; G Keser; S Yavuz; M Birlik; A M Onat
Journal:  Clin Rheumatol       Date:  2016-04-27       Impact factor: 2.980

9.  Risk of cancer in patients with scleroderma.

Authors:  J E Pearson; A J Silman
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

10.  Next Generation Sequencing identifies mutations in GNPTG gene as a cause of familial form of scleroderma-like disease.

Authors:  Abdelali Zrhidri; Saadia Amasdl; Jaber Lyahyai; Hanane Elouardi; Bouchra Chkirate; Laure Raymond; Grégory Egéa; Mohamed Taoudi; Said El Mouatassim; Abdelaziz Sefiani
Journal:  Pediatr Rheumatol Online J       Date:  2017-09-26       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.